Symrise (SY1) PT Set at €75.00 by UBS Group

UBS Group set a €75.00 ($87.21) target price on Symrise (FRA:SY1) in a research note released on Monday morning, www.boersen-zeitung.de reports. The firm currently has a neutral rating on the stock.

A number of other research firms have also recently commented on SY1. Warburg Research set a €87.00 ($101.16) price target on shares of Symrise and gave the company a buy rating in a report on Monday, February 11th. Independent Research set a €75.00 ($87.21) price target on shares of Symrise and gave the company a neutral rating in a report on Monday, February 11th. Deutsche Bank set a €86.00 ($100.00) price target on shares of Symrise and gave the company a buy rating in a report on Friday, February 1st. Goldman Sachs Group set a €73.50 ($85.47) price target on shares of Symrise and gave the company a neutral rating in a report on Friday, February 8th. Finally, JPMorgan Chase & Co. set a €56.00 ($65.12) price target on shares of Symrise and gave the company a sell rating in a report on Friday, February 1st. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and six have assigned a buy rating to the stock. The company has an average rating of Hold and a consensus target price of €72.73 ($84.56).

FRA:SY1 opened at €77.84 ($90.51) on Monday. Symrise has a 52 week low of €56.96 ($66.23) and a 52 week high of €73.48 ($85.44).

About Symrise

Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

Recommended Story: Strangles

Analyst Recommendations for Symrise (FRA:SY1)

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit